(2R)-2-[[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl]-Butanoic acid is a chiral, non-proteinogenic amino acid derivative. Its structure features a butanoic acid backbone with an amino group protected by the 9-fluorenylmethoxycarbonyl (Fmoc) group, a standard protecting group in peptide chemistry. The presence of the chiral center at the 2-position (R-configuration) is crucial for its application in stereoselective synthesis. This compound is primarily used as a specialized building block in solid-phase peptide synthesis (SPPS). The Fmoc-protected amino group allows for its controlled incorporation into peptide chains, while the carboxylic acid moiety serves as the point of attachment to the resin or for chain elongation. Its non-natural side chain structure makes it valuable for introducing specific conformational constraints or novel functionalities into synthetic peptides and peptidomimetics, which are essential tools in medicinal chemistry for drug discovery and biochemical research. As a well-defined chiral synthon, it also finds utility in organic synthesis beyond peptide applications, particularly in the construction of complex molecules requiring specific stereochemistry and functional group arrays.